Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/23208
Title: Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: the case of rosiglitazone
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adverse Drug Reaction Reporting Systems,Cardiovascular Diseases/*chemically induced/epidemiology,Dose-Response Relationship, Drug,Drug Administration Schedule,Female,Humans,Hypoglycemic Agents/*adverse effects/therapeutic use,Incidence,Male,*Meta-Analysis as Topic,Randomized Controlled Trials as Topic,Rare Diseases,Reproducibility of Results,Risk Assessment,Sensitivity and Specificity,Thiazolidinediones/*adverse effects/therapeutic use
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/23208
ISSN: 1097-6744
Link: http://www.ncbi.nlm.nih.gov/pubmed/18585493
http://ac.els-cdn.com/S0002870308001622/1-s2.0-S0002870308001622-main.pdf?_tid=829091dfa1746f53354092b0eb394698&acdnat=1333363794_ba88eeb65d374de8425588c77419be0c
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Hernandez-2008-Challenges in meta-a.pdf191.2 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons